16325809|t|FK962, a novel enhancer of somatostatin release, exerts cognitive-enhancing actions in rats.
16325809|a|FK962 (N-(1-acetylpiperidin-4-yl)-4-fluorobenzamide) is a derivative of FK960 (N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate), with putative anti-dementia properties. Here, we wanted to determine whether FK962 retained the ability of the parent compound to both facilitate somatostatinergic nerve activity in hippocampal neurons and to ameliorate cognitive dysfunction in rat models. FK962 (10(-9) - 10(- 6) M) significantly enhanced high K+-evoked somatostatin release from rat hippocampal slices. FK962 also significantly reduced somatostatin-induced inhibition of Ca2+ channels at 10(-9) - 10(-7) M in single rat hippocampal neurons using whole-cell patch-clamp. Furthermore, administration of FK962 (0.032-3.2 mg/kg, i.p.) significantly ameliorated memory deficits in passive avoidance task in animal models: scopolamine-treated rats, nucleus basalis magnocellularis-lesioned rats and aged rats. FK962 (0.01- 1) mg/kg, i.p.) significantly improved spatial memory deficits induced by nucleus basalis magnocellularis-lesion in water maze task. These results suggest that FK962 ameliorates cognitive impairment in rats via activation of the somatostatinergic nervous system in the hippocampus, indicating that FK962 could be a potent cognitive enhancer and therefore might be of therapeutic value for cognitive disorders such as Alzheimer's disease.
16325809	0	5	FK962	Chemical	MESH:C507659
16325809	27	39	somatostatin	Gene	24797
16325809	87	91	rats	Species	10116
16325809	93	98	FK962	Chemical	MESH:C507659
16325809	100	144	N-(1-acetylpiperidin-4-yl)-4-fluorobenzamide	Chemical	MESH:C507659
16325809	165	170	FK960	Chemical	MESH:C102991
16325809	172	228	N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate	Chemical	-
16325809	250	258	dementia	Disease	MESH:D003704
16325809	308	313	FK962	Chemical	MESH:C507659
16325809	451	472	cognitive dysfunction	Disease	MESH:D003072
16325809	476	479	rat	Species	10116
16325809	488	493	FK962	Chemical	MESH:C507659
16325809	553	565	somatostatin	Gene	24797
16325809	579	582	rat	Species	10116
16325809	603	608	FK962	Chemical	MESH:C507659
16325809	636	648	somatostatin	Gene	24797
16325809	671	675	Ca2+	Chemical	-
16325809	716	719	rat	Species	10116
16325809	801	806	FK962	Chemical	MESH:C507659
16325809	857	872	memory deficits	Disease	MESH:D008569
16325809	917	928	scopolamine	Chemical	MESH:D012601
16325809	937	941	rats	Species	10116
16325809	951	974	basalis magnocellularis	Chemical	-
16325809	984	988	rats	Species	10116
16325809	998	1002	rats	Species	10116
16325809	1004	1009	FK962	Chemical	MESH:C507659
16325809	1064	1079	memory deficits	Disease	MESH:D008569
16325809	1099	1122	basalis magnocellularis	Chemical	-
16325809	1177	1182	FK962	Chemical	MESH:C507659
16325809	1195	1215	cognitive impairment	Disease	MESH:D003072
16325809	1219	1223	rats	Species	10116
16325809	1315	1320	FK962	Chemical	MESH:C507659
16325809	1406	1425	cognitive disorders	Disease	MESH:D003072
16325809	1434	1453	Alzheimer's disease	Disease	MESH:D000544
16325809	Positive_Correlation	MESH:D012601	MESH:D008569
16325809	Negative_Correlation	MESH:C507659	MESH:D003072
16325809	Positive_Correlation	MESH:C507659	24797
16325809	Negative_Correlation	MESH:C507659	MESH:D000544
16325809	Comparison	MESH:C102991	MESH:C507659
16325809	Negative_Correlation	MESH:C507659	MESH:D003704
16325809	Negative_Correlation	MESH:C102991	MESH:D003704
16325809	Negative_Correlation	MESH:C507659	MESH:D008569
16325809	Negative_Correlation	MESH:C507659	MESH:D012601

